Suppr超能文献

代谢相关性脂肪性肝病/代谢相关脂肪性肝病的管理:从药物治疗到营养干预。

Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions.

机构信息

Department of Agricultural Biotechnology, College of Agriculture, Isfahan University of Technology (IUT), Isfahan 8415683111, Iran.

Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom 7414846199, Iran.

出版信息

Nutrients. 2024 Jul 11;16(14):2220. doi: 10.3390/nu16142220.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common long-lasting liver disease that affects millions of people around the world. It is best identified with a hepatic fat build-up that ultimately leads to inflammation and damage. The classification and nomenclature of NAFLD have long been a controversial topic, until 2020 when a group of international experts recommended substituting NAFLD with MAFLD (metabolic dysfunction-associated FLD). MAFLD was then terminologically complemented in 2023 by altering it to MASLD, i.e., metabolic dysfunction-associated steatotic liver disease (MASLD). Both the MAFLD and the MASLD terminologies comprise the metabolic element of the disorder, as they offer diagnostic benchmarks that are embedded in the metabolic risk factors that underlie the disease. MASLD (as a multisystemic disease) provides a comprehensive definition that includes a larger population of patients who are at risk of liver morbidity and mortality, as well as adverse cardiovascular and diabetes outcomes. MASLD highlights metabolic risks in lean or normal weight individuals, a factor that has not been accentuated or discussed in previous guidelines. Novel antihyperglycemic agents, anti-hyperlipidemic drugs, lifestyle modifications, nutritional interventions, and exercise therapies have not been extensively studied in MAFLD and MASLD. Nutrition plays a vital role in managing both conditions, where centralizing on a diet rich in whole vegetables, fruits, foods, healthy fats, lean proteins, and specific nutrients (e.g., omega-3 fatty acids and fibers) can improve insulin resistance and reduce inflammation. Thus, it is essential to understand the role of nutrition in managing these conditions and to work with patients to develop an individualized plan for optimal health. This review discusses prevention strategies for NAFLD/MAFLD/MASLD management, with particular attention to nutrition and lifestyle correction.

摘要

非酒精性脂肪性肝病 (NAFLD) 是一种常见的长期肝脏疾病,影响着全球数百万人。它最好通过肝内脂肪堆积来识别,最终导致炎症和损伤。NAFLD 的分类和命名长期以来一直是一个有争议的话题,直到 2020 年,一组国际专家建议用 MAFLD(代谢功能障碍相关的 FLD)取代 NAFLD。然后,在 2023 年,通过改变其为 MASLD,即代谢功能障碍相关脂肪性肝病 (MASLD),对 MAFLD 进行了术语上的补充。MAFLD 和 MASLD 这两个术语都包含了该疾病的代谢成分,因为它们提供了嵌入疾病潜在代谢风险因素中的诊断基准。MASLD(作为一种全身性疾病)提供了一个全面的定义,包括了更大的处于肝脏发病率和死亡率风险以及不良心血管和糖尿病结局的患者群体。MASLD 强调了瘦或正常体重个体中的代谢风险,这是以前的指南中没有强调或讨论过的因素。新型降糖药、降脂药、生活方式改变、营养干预和运动疗法在 MAFLD 和 MASLD 中尚未得到广泛研究。营养在这两种疾病的管理中起着至关重要的作用,集中于富含全蔬菜、水果、健康脂肪、瘦肉蛋白和特定营养素(如欧米伽 3 脂肪酸和纤维)的饮食可以改善胰岛素抵抗和减轻炎症。因此,了解营养在管理这些疾病中的作用并与患者合作制定最佳健康的个体化计划至关重要。本综述讨论了 NAFLD/MAFLD/MASLD 管理的预防策略,特别关注营养和生活方式纠正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d813/11279539/64e0544340b6/nutrients-16-02220-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验